| Schedule of Related Parties Transactions |
Amounts
due from related parties consisted of the following as of December 31, 2025 and 2024:
| | |
December 31,
2025 | | |
December 31,
2024 | |
| Current | |
| | |
| |
| Libra
Sciences Limited (Note b) | |
| 522,192 | | |
| 522,192 | |
| Allowance
for credit loss | |
| (522,192 | ) | |
| (522,192 | ) |
| Total | |
$ | — | | |
$ | — | |
Amounts
due to related parties consisted of the following as of December 31, 2025 and 2024:
| |
|
December 31,
2025 |
|
|
December 31,
2024 |
|
| Current |
|
|
|
|
|
|
| Aeneas Group Limited (Note a) |
|
$ |
79,180 |
|
|
$ |
79,180 |
|
| Ian Huen |
|
|
— |
|
|
|
464 |
|
| |
|
$ |
79,180 |
|
|
$ |
79,644 |
|
| Convertible notes to a related party |
|
|
|
|
|
|
|
|
| Jurchen Investment Corporation (Note 15) |
|
|
3,418,500 |
|
|
|
3,238,500 |
|
| Total |
|
$ |
3,418,500 |
|
|
$ |
3,238,500 |
|
Related
party transactions consisted of the following for the years ended December 31, 2025, 2024 and 2023:
| | |
Year
ended December 31, 2025 | | |
Year
ended December 31, 2024 | | |
Year
ended December 31, 2023 | |
| Loan from related parties
(Note a) | |
| | |
| | |
| |
| -
Aeneas Group Limited | |
$ | - | | |
$ | - | | |
$ | 2,500,000 | |
| | |
| | | |
| | | |
| | |
| Issuance
of Convertible Note to related parties (Note 15) | |
| | | |
| | | |
| | |
| -
Jurchen Investment Corporation | |
$ | - | | |
$ | - | | |
$ | 3,000,000 | |
| | |
| | | |
| | | |
| | |
| Settlement
of loan from a related party through issuance of Convertible Note (Note 15) | |
| | | |
| | | |
| | |
| -
Aeneas Group Limited | |
$ | - | | |
$ | - | | |
$ | 3,000,000 | |
| | |
| | | |
| | | |
| | |
| Interest
expenses (Note a and Note 15) | |
| | | |
| | | |
| | |
| -
Aeneas Group Limited | |
$ | - | | |
$ | - | | |
$ | 71,123 | |
| -
Jurchen Investment Corporation | |
$ | 180,000 | | |
$ | 180,000 | | |
$ | 58,500 | |
| -
Aenco Technologies Ltd | |
$ | - | | |
$ | - | | |
$ | (13,234 | ) |
| | |
| | | |
| | | |
| | |
| Loan
to related parties (Note b) | |
| | | |
| | | |
| | |
| -
Libra Sciences Limited | |
$ | - | | |
$ | - | | |
$ | 92,459 | |
| | |
| | | |
| | | |
| | |
| Loan
repayment and interest received from a related party (Note b) | |
| | | |
| | | |
| | |
| -
Talem Medical Group Limited | |
$ | - | | |
$ | - | | |
$ | 611,641 | |
| | |
| | | |
| | | |
| | |
| Interest
income (Note b) | |
| | | |
| | | |
| | |
| -
Talem Medical Group Limited | |
$ | - | | |
$ | - | | |
$ | 4,637 | |
| -
Libra Sciences Limited | |
$ | - | | |
$ | - | | |
$ | 8,963 | |
| | |
| | | |
| | | |
| | |
| Consultant,
secondment, management and administrative services fees (Note c) | |
| | | |
| | | |
| | |
| -
CGY Investments Limited | |
$ | - | | |
$ | - | | |
$ | 153,640 | |
| -
ACC Medical Limited | |
$ | - | | |
$ | - | | |
$ | 138,768 | |
| | |
| | | |
| | | |
| | |
| Administrative
management services (Note d) | |
| | | |
| | | |
| | |
| -
Libra Sciences Limited | |
$ | - | | |
$ | - | | |
$ | 9,615 | |
| | |
| | | |
| | | |
| | |
| Healthcare
services income | |
| | | |
| | | |
| | |
| -
Aeneas Management Limited | |
$ | - | | |
$ | - | | |
$ | 961 | |
|